Literature DB >> 17279462

Disposition kinetics, urinary excretion and dosage regimen of levofloxacin formulation following single intravenous administration in crossbred calves.

V K Dumka1, A K Srivastava.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17279462     DOI： 10.1007/s11259-007-0090-8

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN： 0165-7380            Impact factor:   2.459


× No keyword cloud information.
  15 in total

1.  Pharmacokinetics of levofloxacin in healthy Thai male volunteers.

Authors:  S Chulavatnatol; B Chindavijak; A Vibhagool; W Wananukul; C Sriapha; C Sirisangtragul
Journal:  J Med Assoc Thai       Date:  1999-11

2.  Some pharmacokinetic data for danofloxacin in healthy goats.

Authors:  M Atef; A Y El-Gendi; M M Amer; A M Abd El-Aty
Journal:  Vet Res Commun       Date:  2001-07       Impact factor: 2.459

3.  Pharmacokinetics of ofloxacin enantiomers after intravenous administration for antibiotic prophylaxis in biliary surgery.

Authors:  A R Gascón; E Campo; R M Hernández; B Calvo; J Errasti; J L Pedraz Muñoz
Journal:  J Clin Pharmacol       Date:  2000-08       Impact factor: 3.126

4.  Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.

Authors:  S C Chien; A T Chow; M C Rogge; R R Williams; C W Hendrix
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

5.  Pharmacokinetics of levofloxacin in comparison to the racemic mixture of ofloxacin in man.

Authors:  M Verho; V Malerczyk; D Damm; K H Lehr
Journal:  Drug Metabol Drug Interact       Date:  1996

6.  Outline of details for microbiological assays of antibiotics: second revision.

Authors:  B Arret; D P Johnson; A Kirshbaum
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

7.  A randomized, crossover design study of the pharmacology of extended-spectrum fluoroquinolones for pneumococcal infections.

Authors:  G W Amsden; D M Graci; L J Cabelus; L G Hejmanowski
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

8.  In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.

Authors:  P H Edelstein; M A Edelstein; K H Lehr; J Ren
Journal:  J Antimicrob Chemother       Date:  1996-01       Impact factor: 5.790

9.  Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals.

Authors:  N Klesel; K H Geweniger; P Koletzki; D Isert; M Limbert; A Markus; G Riess; H Schramm; P Iyer
Journal:  J Antimicrob Chemother       Date:  1995-06       Impact factor: 5.790

Review 10.  Levofloxacin, a second-generation fluoroquinolone.

Authors:  D S North; D N Fish; J J Redington
Journal:  Pharmacotherapy       Date:  1998 Sep-Oct       Impact factor: 4.705
View more
  3 in total

1.  Disposition kinetics of levofloxacin in sheep after intravenous and intramuscular administration.

Authors:  Ayman Goudah; Sherifa Hasabelnaby
Journal:  Vet Med Int       Date:  2010-11-02

2.  Disposition kinetics and dosage regimen of levofloxacin on concomitant administration with paracetamol in crossbred calves.

Authors:  Vinod K Dumka
Journal:  J Vet Sci       Date:  2007-12       Impact factor: 1.672

3.  Comparative Pharmacokinetics of Levofloxacin in Healthy and Renal Damaged Muscovy Ducks following Intravenous and Oral Administration.

Authors:  Mohamed Aboubakr; Ahmed Soliman
Journal:  Vet Med Int       Date:  2014-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.